Insys Therapeutics Inc. (fka INSYQ)

[terry hallinan]

"Insys also believes its formulation can offer longer shelf-life, which is another potential advantage easily overlooked by investors," Trbovich said.

But don't investors want faster turnover instead of slower?

Sorry for a beastly sense of humor.

This appears to be one announcement of unalloyed good news if nothing else crops up.

Thanks from me too.

Best, Terry